Literature DB >> 16596146

Extramedullary relapse of multiple myeloma presenting as hematemesis and melena.

Mark A Dawson1, Mark N Polizzotto, Adam Gordon, Stuart K Roberts, Andrew Spencer.   

Abstract

BACKGROUND: A 60-year-old woman with multiple myeloma relapsed after a good partial response to high-dose chemotherapy (melphalan 200 mg/m(2)) and autologous stem-cell transplantation, followed by thalidomide and prednisolone maintenance therapy. She presented with hematemesis and melena following salvage chemotherapy with dexamethasone, cyclophosphamide, etoposide, cisplatin, and rescue therapy with single-agent bortezomib. INVESTIGATIONS: Physical examination, laboratory investigations, gastroscopy, 2-[(18)F]fluoro-2-deoxyglucose-PET (FDG-PET), breast biopsy and histology. DIAGNOSIS: Multifocal extramedullary relapse of multiple myeloma involving the stomach and duodenum. MANAGEMENT: High-dose infusion of omeprazole, blood product support, palliative analgesics and anxiolytic agents.

Entities:  

Mesh:

Year:  2006        PMID: 16596146     DOI: 10.1038/ncponc0454

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


  4 in total

1.  Gastrointestinal bleeding as an initial manifestation in asymptomatic multiple myeloma: A case report and review of the literature.

Authors:  Maosong Lin; Jiayi Zhu; Hongzhang Shen; Junxing Huang
Journal:  Oncol Lett       Date:  2012-10-01       Impact factor: 2.967

Review 2.  Extramedullary plasmacytoma mimicking colon carcinoma: an unusual presentation and review of the literature.

Authors:  Kaela Parnell; Mashrafi Ahmed; Roger D Smalligan; Suhasini Nadesan
Journal:  BMJ Case Rep       Date:  2015-10-23

3.  Gastrointestinal relapse of multiple myeloma and sustained response to lenalidomide: a case report.

Authors:  Patrick R Benusiglio; Thomas A McKee; Xavier Montet; Jean-Marc Dumonceau; Laurence Favet; Anne-Claude George; Pierre-Yves Dietrich
Journal:  J Med Case Rep       Date:  2011-03-19

4.  Successful Treatment of Gastric Relapse in Multiple Myeloma with Bortezomib after Autologous Hematopoietic Stem Cell Transplantation (autoHSCT).

Authors:  Serdar Sivgin; Suleyman Baldane; Leylagul Kaynar; Fatih Kurnaz; Mevlut Baskol; Mustafa Kula; Celalettin Eroglu; Kemal Deniz; Bulent Eser; Ali Unal; Mustafa Cetin
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.